Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives $105.50 Consensus Price Target from Analysts
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) has earned an average recommendation of “Moderate Buy” from the ten analysts that are covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average twelve-month price target among […]
More Stories
Nuveen Asset Management LLC Trims Holdings in National Fuel Gas (NYSE:NFG)
Nuveen Asset Management LLC lessened its holdings in shares of National Fuel Gas (NYSE:NFG – Free Report) by 10.4% during...
79,507 Shares in Informatica Inc. (NYSE:INFA) Bought by Squarepoint Ops LLC
Squarepoint Ops LLC bought a new position in shares of Informatica Inc. (NYSE:INFA – Free Report) during the fourth quarter,...
Amazon.com, Inc. (NASDAQ:AMZN) Stock Position Increased by Quadcap Wealth Management LLC
Quadcap Wealth Management LLC grew its stake in shares of Amazon.com, Inc. (NASDAQ:AMZN) by 3.2% during the fourth quarter, according...
Main Management ETF Advisors LLC Sells 3,904 Shares of NVIDIA Co. (NASDAQ:NVDA)
Main Management ETF Advisors LLC reduced its holdings in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 8.2% during...
Nuveen Asset Management LLC Increases Holdings in Sonic Automotive, Inc. (NYSE:SAH)
Nuveen Asset Management LLC grew its holdings in Sonic Automotive, Inc. (NYSE:SAH – Free Report) by 1.1% during the 4th...
Squarepoint Ops LLC Has $2.23 Million Stake in Alignment Healthcare, Inc. (NASDAQ:ALHC)
Squarepoint Ops LLC increased its holdings in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC – Free Report) by 414.6% in the...